FABLE THERAPEUTICS Trademark

Trademark Overview


On Tuesday, November 12, 2024, a trademark application was filed for FABLE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the FABLE THERAPEUTICS trademark a serial number of 98849309. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, November 12, 2024. This trademark is owned by Fable Therapeutics, Inc.. The FABLE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; pharmaceutical research and development services; providing online non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information; providing online non-downloadable computer software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; software as a service (SAAS) services featuring software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; providing an online non-downloadable computer software platform for discovering proteins or drugs, forecasting potential uses of proteins or drug compounds and generating insights from screening and analyzing molecules, feat...
fable therapeutics

General Information


Serial Number98849309
Word MarkFABLE THERAPEUTICS
Filing DateTuesday, November 12, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; pharmaceutical research and development services; providing online non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information; providing online non-downloadable computer software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; software as a service (SAAS) services featuring software for use in generating, analyzing, and accessing data via artificial intelligence and machine learning; providing an online non-downloadable computer software platform for discovering proteins or drugs, forecasting potential uses of proteins or drug compounds and generating insights from screening and analyzing molecules, featuring software using artificial intelligence and machine learning; providing temporary use of non-downloadable computer software for discovering proteins or drugs, forecasting potential uses of proteins or drug compounds and generating insights from screening and analyzing molecules, all using artificial intelligence and machine learning; software as a service (SAAS) services featuring software for discovering proteins or drugs, forecasting potential uses of proteins or drug compounds and generating insights from screening and analyzing molecules, all using artificial intelligence and machine learning; providing an online non-downloadable computer software platform for analyzing molecular data; providing temporary use of non-downloadable computer software for generating or analyzing molecular data for biotechnology and pharmaceutical companies; software as a service (SAAS) services featuring software for generating or analyzing molecular data for biotechnology and pharmaceutical companies; preclinical drug discovery and development services used for identifying, designing, and optimizing chemical or biological compounds; pharmaceutical evaluation and preclinical evaluation of biological or chemical series and biological or chemical compounds in drug discovery; pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing biological or chemical series and biological or chemical compounds via software using artificial intelligence and machine learning; providing an online searchable database in the fields of proteins or pharmaceuticals for scientific research purposes, in particular, pharmaceutical research and development, scientific research and development of proteins or pharmaceutical preparations, scientific development of new uses for proteins or pharmaceutical compounds, and scientific technical research; scientific research and development for forecasting the use of molecules as diagnostics, prognostics, or drug compounds and developing new uses for pharmaceutical compounds; research and development in the field of drug discovery and development, diagnostics or prognostics; drug discovery services, namely, discovering novel molecules to develop into drug compounds; medical research and development in the field of biopharmaceuticals, diagnostics, prognostics, or protein engineering

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 12, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFable Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, November 12, 2024NEW APPLICATION ENTERED